Loading company…
Riskpilot
← Back to search
Sign in
Get full access
VITUSAPOTEK GEILO AS
AS
Active
Org 932529432
Kyrkjevegen 1A, 3580 Geilo
Retail sale of pharmaceutical products · NACE 4773
Est. 2023
11 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 19,5M
EBITDA margin
7.6%
+2026% vs 2023
Equity ratio
14.3%
Financial strength
Net profit 2024
NOK 914K
+1285% vs 2023
EBITDA — year on year
NOK millions
1M
1M
1M
0M
0M
0M
2023
1M
+100%
2024
Key figures
Annual report 2024
Revenue
NOK 19,5M
—
EBITDA
NOK 1,5M
+2026%
Net profit
NOK 914K
+1285%
Total assets
NOK 6,5M
+293%
Equity
NOK 931K
+5261%
Employees
11
—
Company information
Legal name
VITUSAPOTEK GEILO AS
Org number
932529432
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
29. november 2023
Share capital
NOK 100 000
Employees
11 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Styrets leder og ett styremedlem i fellesskap. Daglig leder og ett styremedlem i fellesskap.
Company purpose
Drive apotek, salg av apotekvarer og tilhørende farmasøytiske tjenester og oppgaver.
Contact
Address
Kyrkjevegen 1A, 3580 Geilo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of pharmaceutical products
Companies in Hol
All Norway companies
Revenue
NOK millions
0M
5M
11M
16M
22M
0M
2023
19M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2023
1M
2024
Income statement
NOK thousands
Item
2023
2024
Revenue
0
19 481
Staff expenses
−0
−3 264
EBITDA
−77
1 484
Depreciation & amort.
−0
−191
EBIT
−77
1 293
Net financials
0
−142
Profit before tax
−77
1 151
Tax
−0
238
Net profit
−77
914
Balance sheet
NOK thousands
Item
2023
2024
Total assets
1 656
6 514
Equity
17
931
Long-term debt
1 500
2 034
Short-term debt
138
3 549
Total debt
1 638
5 584
Financial ratios
5-year trend
EBITDA margin
7.6%
This company
15.8%
Market median
-52% vs market
2023
2024
Equity ratio
14.3%
This company
38.2%
Market median
-63% vs market
2023
2024
Return on equity
98.1%
This company
18.4%
Market median
+433% vs market
2023
2024
Net profit margin
4.7%
This company
8.1%
Market median
-42% vs market
2023
2024
Asset turnover
2.99×
This company
1.12×
Market median
+167% vs market
2023
2024
Debt / equity
6.00×
This company
0.62×
Market median
-868% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-11-03 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AE
Anders Eimstad Rasmushaugen
Chief Executive Officer
Chief Executive Officer
2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
MW
Michael William Rasmushaugen Eimstad
Chairman
2023
KF
Kristin Flaata Brunvoll
Board of Directors
2023
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Vikenapotekene As
Company
75%
75%
2024
Ditt Apotek Rødberg As
Company
25%
25%
2024
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Mckesson Norway Holding As
Norsk Medisinaldepot As
Vikenapotekene As
VITUSAPOTEK GEILO AS
(this company)
Board network connections
Board members of VITUSAPOTEK GEILO AS also hold positions in
0
other companies.
Person
Role here
Other companies
Anders Eimstad Rasmushaugen
Chief Executive Officer
0 companies
Michael William Rasmushaugen Eimstad
Chairman
0 companies
Kristin Flaata Brunvoll
Board of Directors
0 companies